This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Medical Practice  • Conflict of Interest  • Law and Medicine  • Alert me on articles by topic  Social Bookmarking   What's this?

Mike Mitka

JAMA. 2009;301(10):1011.

	Since this article does not have an abstract, we have provided the first 117 words of the full text and any section headings.

A bill introduced in the Senate seeks to require makers of pharmaceuticals, medical devices, and biologics to publicly report payments to physicians that exceed $100 annually. Under provisions of the Physician Payments Sunshine Act of 2009 (S 301 [http://thomas.loc.gov]), these manufacturers would report their payments to the Department of Health and Human Services, which would post them online for public viewing.

The bill was introduced by Sen Chuck Grassley (R, Iowa) and Sen Herb Kohl (D, Wis), who submitted similar legislation 2 years ago that the 110th Congress never considered. The bill also would create a federal "academic detailing" program to give physicians an objective source of information based on independent scientific research.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?